|
Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression
|
18 August 2014 |
|
Melatonin in pathogenesis and therapy of cancer
|
15 August 2014 |
|
Retinoid, retinoic acid receptor beta and breast cancer
|
15 August 2014 |
|
Vitamin D and skin cancer
|
14 August 2014 |
|
Kinetic studies of 25-hydroxy-19-nor-vitamin D3 and 1 alpha,25-dihydroxy-19-nor-vitamin D3 hydroxylation by CYP27B1 and CYP24A1
|
12 August 2014 |
|
1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases
|
11 August 2014 |
|
Differentiating agents in pediatric malignancies: retinoids in neuroblastoma
|
08 August 2014 |
|
Somatostatin receptors in gliomas
|
07 August 2014 |
|
Studies of the effects of 1,25-dihydroxyvitamin D on skeletal and calcium homeostasis and on inhibition of tumor cell growth
|
07 August 2014 |
|
Preoperative growth inhibition of human gastric adenocarcinoma treated with a combination of celecoxib and octreotide
|
06 August 2014 |